US Drug Recall Register
Class II · Moderate risk Completed Initiated Nov 22, 2023 (3 years ago)

ceFAZolin sodium in Sterile Water for injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility.

What was recalled

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

Recalling firm
Wells Pharma of Houston LLC
NDC code
73702-131-10
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0141-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cefazolin recalls

See all
Class I · High risk Ongoing

Cefazolin for Injection

Reason Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin

Sandoz Inc D-0569-2025
Class II · Moderate risk Terminated

Cefazolin

Reason Lack of sterility assurance

Sentara Infusion Services D-0278-2023
Class II · Moderate risk Terminated

Cefazolin for injection USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0264-3105-11 D-1118-2022
Class II · Moderate risk Terminated

Cefazolin for injection USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0264-3103-11 D-1117-2022